A highly sensitive immunofluorometric assay for the measurement of aldosterone in small sample volumes: Validation in mouse serum

Journal of Endocrinology

Volumn 196, Issue 2, 2008, Pages 215-224

  Manolopoulou, J ^a   Bielohuby, M ^a,b   Caton, S J ^a   Gomez Sanchez, C E ^c   Renner Mueller, I ^b   Wolf, E ^b   Lichtenauer, U D ^d   Beuschlein, F ^a   Hoeflich, A ^b,e   Bidlingmaier, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d UNIVERSITY OF FREIBURG   (Germany)

^e Research Unit Genetics and Biometry   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CORTICOTROPIN; DEXAMETHASONE;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; FEMALE; GENOTYPE; IMMUNOFLUORESCENCE TEST; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SENSITIVITY ANALYSIS; STEROIDOGENESIS; VALIDATION PROCESS;

AGING; ALDOSTERONE; ANIMALS; CHROMATOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUORESCENCE; FLUOROIMMUNOASSAY; HUMANS; MALE; MICE; MICE, INBRED STRAINS; POTASSIUM, DIETARY; RENIN-ANGIOTENSIN SYSTEM; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 39749186540     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-07-0134     Document Type: Article

References (46)

1. Abayasekara DRE, Onyezili NI, Whitehouse BJ, Laird SM & Vinson GP 1993 Effects of chronic corticotrophin treatment on aldosterone metabolism in the rat. Journal of Endocrinology 137 445-455.
2. Abraham GE, Buster JE, Lucas LA, Corrales PC & Teller RC 1972 Chromatographic separation of steroid hormones for use in immunoassay. Analytical Letters 5 509-517.
3. Alia P, Villabona C, Gimenez O, Sospedra E, Soler J & Navarro MA 2006 Profile, mean residence time of ACTH and cortisol responses after low and standard ACTH tests in healthy volunteers. Clinical Endocrinology 65 346-351.
4. Arrighi I, Bloch-Faure M, Grahammer F, Bleich M, Warth R, Mengual R, Drici MD, Barhanin J & Meneton P 2001 Altered potassium balance and aldosterone secretion in a mouse model of human congenital long QT syndrome. PNAS 98 8792-8797.
5. Atkinson HC & Waddell BJ 1997 Circadian variation in basal plasma corticosterone and adrenocorticotropin in the rat: sexual dimorphism and changes across the estrous cycle. Endocrinology 138 3842-3848.
6. Berger S, Bleich M, Schmid W, Greger R & Schutz G 2000 Mineralocorticoid receptor knockout mice: lessons on Na + metabolism. Kidney International 57 1295-1298.
7. Bielohuby M, Herbach N, Wanke R, Maser-Gluth C, Beuschlein F, Wolf E & Hoeflich A 2007 Growth analysis of the mouse adrenal gland from weaning to adulthood: time- and gender-dependent alterations of cell size and number in the cortical compartment. American Journal of Physiology. Endocrinology and Metabolism 293 E139-E146.
8. Billet S, Bardin S, Tacine R, Clauser E & Conchon S 2006 The ATIA receptor 'gain-of-function' mutant N111S/delta329 is both constitutively active and hyperreactive to angiotensin II. American Journal of Physiology. Endocrinology and Metabolism 290 E840-E848.
9. Cao XR, Shi PP, Sigmund RD, Husted RF, Sigmund CD, Williamson RA, Stokes JB & Yang B 2006 Mice heterozygous for beta-ENaC deletion have defective potassium excretion. American Journal of Physiology. Renal Physiology 291 F107-F115.
10. Cassis LA, Helton MJ, Howatt DA, King VL & Daugherty A 2005 Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. British Journal of Pharmacology 144 443-448.
11. Cole JM, Khokhlova N, Sutliff RL, Adams JW, Disher KM, Zhao H, Capecchi MR, Corvol P & Bernstein KE 2003 Mice lacking endothelial ACE: normal blood pressure with elevated angiotensin II. Hypertension 41 313-321.
12. Coll AP, Challis BG, Yeo GS, Snell K, Piper SJ, Halsall D, Thresher RR & O'Rahilly S 2004 The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin. Endocrinology 145 4721-4727.
13. Coll AP, Fassnacht M, Klammer S, Habner S, Schulte DM, Piper S, Tong YC, Challis BG, Weinstein Y, Allolio B et al. 2006 Peripheral administration of the N-ternmial pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production. Journal of Endocrinology 190 515-525.
14. Davies E, Omer S, Buckingham JC, Morris JF & Christian HC 2007 Expression and externalization of annexin 1 in the adrenal gland: structure and function of the adrenal gland in annexin 1-null mutant mice. Endocrinology 148 1030-1038.
15. Dressendorfer RA, Kirschbaum C, Rohde W, Stahl F & Strasburger CJ 1992 Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. Journal of Steroid Biochemistry 43 683-692.
16. Gomez-Sanchez CE, Foecking MF, Ferris MW, Chavarri MR, Uribe L & Gomez-Sanchez EP 1987 The production of monoclonal antibodies against aldosterone. Steroids 49 581-587.
17. Hanquez C, Rajkowski KM, Desfosses B & Cittanova N 1988 A competitive microtitre plate enzyme immunoassay for plasma alclosterone using a monoclonal antibody. Journal of Steroid Biochemistry 31 939-945.
18. Hoeflich A, Weber MM, Fisch T, Nedbal S, Fottner C, Elmlinger MW, Wanke R & Wolf E 2002 Insulin-like growth factor binding protein 2 (IGFBP-2) separates hypertrophic and hyperplastic effects of growth hormone (GH)/ IGF-I excess on adrenocortical cells in vivo. FASEB Journal 16 1721-1731.
19. Jensen BL, Stubbe J, Madsen K, Nielsen FT & Skott O 2004 The renin-angiotensin system in kidney development: role of COX-2 and adrenal steroids. Acta Physiologica Scandinavica 181 549-559.
20. Karpac J, Ostwald D, Bui S, Hunnewell P, Shankar M & Hochgeschwender U 2005 Development, maintenance, and function of the adrenal gland in early postnatal proopiomelanocortin-null mutant mice. Endocrinology 146 2555-2562.
21. Kessler SP, Hashimoto S, Senanayake PS, Gaughan C, Sen GC & Schnermann J 2005 Nephron function in transgenic mice with selective vascular or tubular expression ofangiotensin-converting enzyme. Journal of the American Society of Nephrology 16 3535-3542.
22. de Lauzon S, Le Trang N, Moreau MF, Gentin M, Christeff N, Desfosses B & Cittanova M 1987 Murine monoclonal antibody against aldosterone: production, characterization and use for enzymoimmunoassay. Journal of Steroid Biochemistry 28 459-463.
23. Lee G, Makhanova N, Caron K, Lopez ML, Gomez RA, Smithies O & Kim HS 2005 Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice. Endocrinology 146 2650-2656.
24. Makhanova N, Sequeira-Lopez ML, Gomez RA, Kim HS & Smithies O 2006 Disturbed homeostasis in sodium-restricted mice heterozygous and homozygous for aldosterone synthase gene disruption. Hypertension 48 1151-1159.
25. Miller MA, Sagnella GA & MacGregor GA 1997 Extraction method and nonextracted kit method compared for measuring plasma aldosterone. Clinical Chemistry 43 1995-1997.
26. Muller J 1995 Aldosterone: the minority hormone of the adrenal cortex. Steroids 60 2-9.
27. Nicklas W, Baneux P, Boot R, Decelle T, Deeny AA, Fumanelli M & Illgen-Wilcke B 2002 Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Laboratory Animals 36 20-42.
28. Nussberger J, Waeber B, Brunner HR, Burris JF & Vetter W 1984 Highly sensitive microassay for alclosterone in unextracted plasma: comparison with two other merhods. Journal of Laboratory and Clinical Medicine 104 789-796.
29. Peters J, Obermuller N, Weryth A, Peters B, Maser-Gluth C, Kranzhn B & Gretz N 1999 Losartan and angiotensin II inhibit aldosterone production in anephric rats via different actions on the intraadrenal renin-angiotensin system. Endocrinology 140 675-682.
30. Peters B, Teubner P, Clausmeyer S, Puschner T, Maser-Gluth C, Wrede HJ, Kranzlin B & Peters J 2007 StAR expression and the long-term aldosterone response to high-potassium diet in Wistar-Kyoto and spontaneously hypertensive rats. American Journal of Physiology. Endocrinology and Metabolism 292 E16-E23.
31. Sausbier M, Arntz C, Bucurenciu I, Zhao H, Zhou XB, Sausbier U, Feil S, Kamm S, Essin K, Sailer CA et al. 2005 Elevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation in BK channel-deficient mice. Circulation 112 60-68.
32. Schirpenbach C, Seiler L, Maser-Gluth C, BeuscWem F, Reincke M & Bidlingmaier M 2006 Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radiominumoassays with and without extraction steps. Clinical Chemistry 52 1749-1755.
33. Schmidt MV, Levine S, Alam S, Harbich D, Sterlemann V, Ganea K,de Kloet ER, Holsboer F & Muller MB 2006 Metabolic signals modulate hypothalamic-pituitary-adrenal axis activation during maternal separation of the neonatal mouse. Journal of Neuroendocrinology 18 865-874.
34. Seely EW, Conlin PR, Brent GA & Dluhy RG 1989 Adrenocorticotropin stimulation of aldosterone: prolonged continuous versus pulsatile infusion. Journal of Clinical Endocrinology and Metabolism 69 1028-1032.
35. Stowasser M & Gordon RD 2006 Monogenic mineralocorticoid hypertension. Best Practice and Research Clinical Endocrinology and Metabolism 20 401-420.
36. Takaya J, Matsusaka T, Katori H, Tamura M, Miyazaki Y, Homma T & Ichikawa I 2001 In situ demonstration of angiotensin-dependent and independent pathways for hyperaldosteronism during chronic extracellular fluid volume depletion. Molecular Endocrinology 15 2229-2235.
37. Tschop M, Behre HM, Nieschlag E, Dressendorfer RA & Strasburger CJ 1998 A time-resolved fluorescence immunoassay for the measurement of testosterone in saliva: monitoring of testosterone replacement therapy with testosterone buciclate. Clinical Chemistry and Laboratory Medicine 36 223-230.
38. Vahl TP, Ulrich-Lai YM, Ostrander MM, Dolgas CM, Elfers EE, Seeley RJ, D'Alessio DA & Herman JP 2005 Comparative analysis of ACTH and corticosterone sampling methods in rats. American Journal of Physiology. Endocrinology and Metabolism 289 E823-E828.
39. Vinson GP 2003 Adrenocortical zonation and ACTH. Microscopy Research and Technique 61 227-239.
40. Vinson GP 2004 Glomerulosa function and aldosterone synthesis in the rat. Molecular and Cellular Endocrinology 217 59-65.
41. Wang Q, Clement S, Gabbiani G, Horisberger JD, Burnier M, Rossier BC & Hummler E 2004 Chronic hyperaldosteronism in a transgenic mouse model fails to induce cardiac remodeling and fibrosis under a normal-salt diet. American Journal of Physiology. Renal Physiology 286 F1178-F1184.
42. Weber MM, Fourier C, Schmidt P, Brodowski KM, Gittner K, Lahm H, Engelhardt D & Wolf E 1999 Postnatal overexpression of insulin-like growth factor II in transgenic mice is associated with adrensicortical hyperplasia and enhanced steroidogenesis. Endocrinology 140 1537-1543.
43. Williams GH 2005a Aldosterone biosynthesis, regulation, and classical mechanism of action. Heart Failure Reviews 10 7-13.
44. Williams GH 2005b Cardiovascular benefits of aldoscerone receptor antagonists: what about potassium? Hypertension 46 265-266.
45. Yaswen L, Diehl N, Brennan MB & Hochgeschwender U 1999 Obesity in the mouse model ofpro-opiomelanocortin deficiency responds to peripheral melanocortin. Nature Medicine 5 1066-1070.
46. Zhang MZ, Wang SW, Cheng H, Zhang Y, McKanna JA & Harris RC 2003 Regulation of renal cortical cyclooxygenase-2 in young rats. American Journal of Physiology. Renal Physiology 285 F881-F888.